The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index; 31 of the 48 sources its claims cite were checked for support.
Cell type- and brain region-resolved mouse brain proteome
Open accessAbstract
Brain transcriptome and connectome maps are being generated, but an equivalent effort on the proteome is currently lacking. We performed high-resolution mass spectrometry-based proteomics for in-depth analysis of the mouse brain and its major brain regions and cell types. Comparisons of the 12,934 identified proteins in oligodendrocytes, astrocytes, microglia and cortical neurons with deep sequencing data of the transcriptome indicated deep coverage of the proteome. Cell type-specific proteins defined as tenfold more abundant than average expression represented about a tenth of the proteome, with an overrepresentation of cell surface proteins. To demonstrate the utility of our resource, we focused on this class of proteins and identified Lsamp, an adhesion molecule of the IgLON family, as a negative regulator of myelination. Our findings provide a framework for a system-level understanding of cell-type diversity in the CNS and serves as a rich resource for analyses of brain development and function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
75 Own result · 24 Own method · 15 Partly supported · 15 Own interpretation · 6 No full text of the sources · 4 Supported · 2 Supported so far · 2 No basis given · 1 Couldn’t confirm · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“this situation has changed with the development of more sensitive and powerful high-resolution mass spectrometry (MS) technologies that allow in-depth coverage of nearly complete proteomes of mammalian cells 13–17.”
§ Cell type– and brain region–resolved mouse brain proteome > Abstract
What the sources say
- Not checked — no full text of the sourcecites [13] Beck, M., Claassen, M. & Aebersold, R. Comprehensive proteomics. Curr. Opin. Biotechnol. 22, 3–8 (2011). source
- Not checked — no full text of the sourcecites [14] Mann, M., Kulak, N.A., Nagaraj, N. & Cox, J. The coming age of complete, accurate, and ubiquitous proteomes. Mol. Cell 49, 583–590 (2013). source
- Supportedcites [15] Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011). source
The Results and discussion state that ultra-deep proteome mapping is becoming possible, with proteins identifiable for nearly all transcripts expected to have a biological function in the cell type. The paper reports deep coverage in human HeLa cells using high-resolution MS, supporting the citing sentence’s broad claim about mammalian-cell proteomes. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [16] Wilhelm, M. et al. Mass-spectrometry-based draft of the human proteome. Nature 509, 582–587 (2014). source
- Partly supportedcites [17] Kim, M.S. et al. A draft map of the human proteome. Nature 509, 575–581 (2014). sourceExperimental — accuracy not yet measured
The Abstract and Discussion report that high-resolution mass spectrometry identified proteins corresponding to about 84% of human protein-coding genes, supporting in-depth coverage of the human proteome. But that coverage was pooled across 30 tissue and cell types; the Discussion describes sampling individual cell types more extensively as future work. The paper therefore does not establish nearly complete coverage of individual mammalian-cell proteomes. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Thus, protein expression analyses are required, but a concerted effort to resolve the brain proteome is missing12.”
§ Cell type– and brain region–resolved mouse brain proteome > Abstract
What the sources say
- Partly supportedcites [12] Kitchen, R.R., Rozowsky, J.S., Gerstein, M.B. & Nairn, A.C. Decoding neuroproteomics: integrating the genome, translatome and functional anatomy. Nat. Neurosci. 17, 1491–1499 (2014). sourceExperimental — accuracy not yet measured
In “Improving the compatibility of proteomics with functional genomics” (page unavailable), the paper says brain-wide protein-localisation and abundance data are far less mature than RNA data and calls for a large-scale quantitative resource. That supports a gap in resolving the brain proteome, but not the stronger assertion that a concerted effort is missing: the same section names the HUPO Brain Proteome Project, and “Challenges in assessing the proteome(s) of the CNS” describes existing studies. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When we excluded these transcripts from our analysis, a standard procedure in RNA-Seq analysis28, the number of genes was reduced to 12,933 (Fig. 1f).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > CNS cell-type proteome depth and quantification
What the sources say
- Could not verifycites [28] Hebenstreit, D. et al. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 7, 497 (2011). sourceExperimental — accuracy not yet measured
The citation is attached to the description of excluding low-abundance transcripts as a standard RNA-seq procedure, not to the citing authors’ count of 12,933 genes. The Results and discussion section describes detection limits at low expression levels, but the passages found do not say that excluding those transcripts is standard practice (searched for filtering and exclusion of low-expression genes). (LLM, conf=0.72)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These iBAQ values yield protein copy number estimates of each protein in the proteome33.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Definition of global differences between CNS cell proteomes
What the sources say
- Partly supportedcites [33] Wiśśniewski, J.R. et al. Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol. Syst. Biol. 8, 611 (2012). sourceExperimental — accuracy not yet measured
The Results section (“Estimation of absolute copy number of proteins”; page unavailable) says the paper estimates protein copy numbers using LFQ intensities and the total protein approach (TPA). It reports that iBAQ gave similar values in a validation calculation, but does not say that iBAQ values themselves yield copy-number estimates for each protein in the proteome. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Taken together with previous estimates of the size of cellular proteomes14,15,29, our data indicate that we have achieved a great depth of coverage of the proteome of glia and neurons.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > CNS cell-type proteome depth and quantification
What the sources say
- Not checked — no full text of the sourcecites [14] Mann, M., Kulak, N.A., Nagaraj, N. & Cox, J. The coming age of complete, accurate, and ubiquitous proteomes. Mol. Cell 49, 583–590 (2013). source
- Supportedcites [15] Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011). source
The citation is attached to “previous estimates of the size of cellular proteomes,” not to the citing authors’ conclusion about glia and neurons. In Results and discussion (page unavailable), the source estimates that at least 10,000–12,000 genes are expressed in HeLa cells, supporting its use as a previous cellular-proteome estimate. (LLM, conf=0.90)
- Supportedcites [29] Beck, M. et al. The quantitative proteome of a human cell line. Mol. Syst. Biol. 7, 549 (2011). source
The citation is attached to “previous estimates of the size of cellular proteomes,” not to the citing authors’ conclusion about their glia and neuron data. The cited paper’s Results report 10,006 proteins identified in the human U2OS cell line, providing the prior cellular-proteome estimate invoked by the sentence. (LLM, conf=0.91)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Given that proteins of the IgLON family promote cell-to-cell adhesion by homo- and heterophilic interactions40,41, they represent ideal candidates for axon and oligodendrocyte interaction.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
What the sources say
- Not checked — no full text of the sourcecites [40] Reed, J., McNamee, C., Rackstraw, S., Jenkins, J. & Moss, D. Diglons are heterodimeric proteins composed of IgLON subunits, and Diglon-CO inhibits neurite outgrowth from cerebellar granule cells. J. Cell Sci. 117, 3961–3973 (2004). source
- Partly supportedcites [41] Gil, O.D., Zanazzi, G., Struyk, A.F. & Salzer, J.L. Neurotrimin mediates bifunctional effects on neurite outgrowth via homophilic and heterophilic interactions. J. Neurosci. 18, 9312–9325 (1998). sourceExperimental — accuracy not yet measured
In “Ntm forms homomeric complexes: potential role in promoting adhesion” (page unavailable), the paper concludes that IgLON family members promote homophilic adhesion. It also suggests heterophilic interactions in neurite outgrowth, but does not establish that those interactions promote cell-to-cell adhesion. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This analysis is supported by data from several large scale, high-resolution, FDR-controlled cellular proteome projects, where the coverage saturated at approximately 11,000 (refs. 15,18,45,46).”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
What the sources say
- Partly supportedcites [15] Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011). sourceExperimental — accuracy not yet measured
The Results and discussion (page unavailable) describe a high-resolution, FDR-controlled HeLa proteome project that identified 10,255 proteins and estimate that 10,000–12,000 genes are expressed in HeLa cells. This supports coverage in the approximate range claimed, but the paper calls its protein count a lower bound and does not show that coverage saturated at approximately 11,000. (LLM, conf=0.85)
- Partly supportedcites [18] Geiger, T., Wehner, A., Schaab, C., Cox, J. & Mann, M. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol. Cell Proteomics 11, M111.014050 (2012). sourceExperimental — accuracy not yet measured
The Results (page unavailable) report a high-resolution analysis of eleven cell lines with a 1% peptide and protein FDR, identifying more than 10,000 proteins per cell line and 11,731 protein groups across the combined analysis. That supports coverage on the order of 11,000, but the paper does not establish that coverage saturated at that level. (LLM, conf=0.86)
- Partly supportedcites [45] Moghaddas Gholami, A. et al. Global proteome analysis of the NCI-60 cell line panel. Cell Rep. 4, 609–620 (2013). sourceExperimental — accuracy not yet measured
The NCI-60 proteome analysis (Figure 1, p. 2) identifies 10,350 distinct proteins, approximately 11,000, and Protein Identification and Quantification (p. 10) specifies a maximum 1% false discovery rate. The paper does not show that coverage saturated at that level; its total is a measured yield, not an established saturation point. It is one of several projects cited by the sentence, so it need not itself report results from several projects. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [46] Azimifar, S.B., Nagaraj, N., Cox, J. & Mann, M. Cell type–resolved quantitative proteomics of murine liver. Cell Metab. 20, 1076–1087 (2014). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We further optimized this technology by extending our single-shot analysis27, which resulted in the detection of more than 11,500 different proteins in only 4-h replicate analysis.”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
What the sources say
- Supportedcites [27] Nagaraj, N. et al. System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap. Mol. Cell Proteomics 11, M111.013722 (2012). source
The citation identifies the earlier single-shot analysis that the citing authors say they further optimized. The source’s Results and Discussion (‘Depth of Analysis of the Yeast Proteome’) describes that workflow and its 4-hour gradients. The figure of more than 11,500 proteins is presented as the citing authors’ subsequent result, not a result attributed to this source. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Combined analysis of the replicates using MaxQuant software26 and applying a peptide and protein false discovery rate (FDR) of 1% identified 13,214 protein groups (Fig.1a,b and Supplementary Table 1).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Adult mouse brain proteome
What the sources say
- Not checked — no full text of the sourcecites [26] Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, in each of the single-shot analyses, we identified more than 11,500 proteins.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Adult mouse brain proteome
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 35
- Probably not a substantial claim. 28
Every source the paper cites for this claim was checked and supports it.
In the paper
“Several studies have reported that quantities of messenger RNA and proteins often correlate poorly, emphasizing the importance of post-transcriptional processes that control protein synthesis and degradation11.”
§ Cell type– and brain region–resolved mouse brain proteome > Abstract
What the sources say
- Supportedcites [11] Vogel, C. & Marcotte, E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227–232 (2012). source
In “Concentrations, production and turnover rates of mRNA and proteins at steady state,” the paper says mRNA and protein abundances correlate, but not strongly. In “Understanding steady-state mRNA and protein levels,” it identifies translation and protein degradation as major contributors to protein abundance beyond mRNA levels. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Previous studies of different human cancer cell lines have found that proteins tend to be ubiquitously expressed with differences in the level of expression of the proteins rather than in their absence or presence18–20.”
§ Cell type– and brain region–resolved mouse brain proteome > Abstract
What the sources say
- Supportedcites [18] Geiger, T., Wehner, A., Schaab, C., Cox, J. & Mann, M. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol. Cell Proteomics 11, M111.014050 (2012). source
The Results report that 8,522 proteins—73% of those identified—were found in all eleven cell lines. The Discussion and Outlook adds that even ubiquitous proteins often vary severalfold in expression between cell lines, supporting the distinction between expression level and presence or absence. (LLM, conf=0.92)
- Supportedcites [19] Lundberg, E. et al. Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 6, 450 (2010). source
The Results and discussion (Antibody-based protein profiling) identifies three human cancer cell lines and reports that 83% of detected proteins were found in all three, while only 6% were exclusive to one. The Conclusions describe differences in expression levels across the lines, supporting the distinction between level and presence or absence. (LLM, conf=0.91)
- Partly supportedcites [20] Pontén, F. et al. A global view of protein expression in human cells, tissues, and organs. Mol. Syst. Biol. 5, 337 (2009). sourceExperimental — accuracy not yet measured
The Results sections on 45 human cell lines and confocal microscopy report that most analyzed proteins were detected across cell lines, while 66% differed in expression level among the three lines examined by confocal microscopy. This supports the expression-level-versus-presence distinction, but our copy describes the lines as human cell lines without establishing the claim’s specific characterization of them as cancer cell lines. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Astrocytes, in contrast, provide nutrients to the nervous tissue, maintain the extracellular ion balance, recycle neurotransmitters, shape synaptic circuits and regulate the blood-brain barrier24.”
§ Cell type– and brain region–resolved mouse brain proteome > Abstract
What the sources say
- Partly supportedcites [24] Molofsky, A.V. et al. Astrocytes and disease: a neurodevelopmental perspective. Genes Dev. 26, 891–907 (2012). sourceExperimental — accuracy not yet measured
“Astrocyte function during normal development” says astrocytes maintain extracellular homeostasis, and “Maturing astrocytes promote synaptogenesis in developing postnatal brains” describes their role in synapse formation. “Other possible developmental functions of astrocytes” says they regulate blood–brain barrier permeability. The passages do not establish the more specific claims that astrocytes provide nutrients or recycle neurotransmitters. (LLM, conf=0.87)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“These low abundance transcripts appear to be the result of rare stochastic transcription and are thought to often result in non-functional mRNAs28.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > CNS cell-type proteome depth and quantification
What the sources say
- Supportedcites [28] Hebenstreit, D. et al. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 7, 497 (2011). source
In Results and discussion (page not provided), the paper concludes that low-expression genes likely reflect ‘leaky’ expression producing non-functional transcripts. It also says most have fewer than one transcript per cell on average and describes their expression as stochastic, matching the claim’s qualified wording. (LLM, conf=0.93)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As previously observed in ultra-deep proteome analysis, a relatively small number of proteins make up for a high proportion of the total protein mass15,34.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Definition of global differences between CNS cell proteomes
What the sources say
- Supportedcites [15] Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011). source
The Results and discussion report that the 40 most abundant proteins comprised 25% of the measured HeLa proteome, while the most abundant 600 constituted 75% of its mass. This directly supports the cited observation that relatively few proteins account for a large share of protein mass. (LLM, conf=0.95)
- Partly supportedcites [34] Marguerat, S. et al. Quantitative analysis of fission yeast transcriptomes and proteomes in proliferating and quiescent cells. Cell 151, 671–683 (2012). sourceExperimental — accuracy not yet measured
In “Coordinated Expression at mRNA and Protein Levels” (page not provided), the paper reports that the 20% most abundant proteins account for 81.3% of protein molecules in proliferating cells. This supports the unequal-abundance point, but the reported proportion is based on molecule counts, not total protein mass. (LLM, conf=0.85)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As observed previously, the abundance of the non-filtered data, expressed as reads per kilobase of exon per million fragments mapped (RPKM), revealed a bimodal distribution (Fig. 1e), where one third of the transcripts have abundances lower than 1 RPKM15,28.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > CNS cell-type proteome depth and quantification
What the sources say
- Supportedcites [15] Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011). source
The Results and discussion section reports that the non-filtered RNA-Seq abundance distribution was bimodal and that about 33% of transcripts had signals below one FPKM. The source uses FPKM rather than RPKM, but it describes the same substantive finding for its single-end sequencing data. (LLM, conf=0.92)
- Partly supportedcites [28] Hebenstreit, D. et al. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 7, 497 (2011). sourceExperimental — accuracy not yet measured
The Results and discussion describe two overlapping expression groups in RNA-seq data, but the RNA-seq distribution has a low-expression shoulder; the paper calls the microarray distribution clearly bimodal. Our copy does not report that one third of transcripts have abundances below 1 RPKM. Its figure of approximately 30% refers instead to genes with no detected reads at a sequencing depth of 25 million reads. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As the correlation between the proteomes and the corresponding transcriptomes was only 0.4 to 0.45,our analysis captured important differences between transcriptome and proteome30,31 (Fig. 2c).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Assessment of proteome quality and comparison to the transcriptome
What the sources say
- Partly supportedcites [30] de Sousa Abreu, R., Penalva, L.O., Marcotte, E.M. & Vogel, C. Global signatures of protein and mRNA expression levels. Mol. Biosyst. 5, 1512–1526 (2009). sourceExperimental — accuracy not yet measured
The section ‘Steady-state concentrations of protein molecules per mRNA and their correlates’ (page not provided) reports that several measurements have R² around 0.4 and that much of the variation in protein levels is not explained by mRNA levels. It does not give 0.4–0.45 as a general correlation coefficient: that figure is approximately a squared Pearson correlation, and the reported values vary across organisms. The citing authors’ statement about what their own analysis captured is their inference, not a finding attributed to this source. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [31] Maier, T., Guell, M. & Serrano, L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 583, 3966–3973 (2009). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Next, we transfected plasmids encoding for full-length Lsamp, Neurotrimin and Opcml tagged with EGFP into HEK293T cells, added soluble Fc fusion proteins and observed homo- and heterophilic interactions as noted previously41 (Supplementary Fig. 10).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
What the sources say
- Partly supportedcites [41] Gil, O.D., Zanazzi, G., Struyk, A.F. & Salzer, J.L. Neurotrimin mediates bifunctional effects on neurite outgrowth via homophilic and heterophilic interactions. J. Neurosci. 18, 9312–9325 (1998). sourceExperimental — accuracy not yet measured
The section “Ntm forms homomeric complexes: potential role in promoting adhesion” reports homophilic binding between neurotrimin-expressing CHO cells and soluble Ntm-Fc. The paper also suggests heterophilic mechanisms in its neurite-outgrowth experiments, but does not establish the homo- and heterophilic interactions among Lsamp, Neurotrimin, and Opcml implied here. The HEK293T/EGFP experiment is the citing authors’ own work, not an experiment attributed to this source. (LLM, conf=0.87)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Lsamp belongs to the IgLON family of adhesion molecules, which also comprises Ntm (neurotrimin), Opcml (opiod-binding cell adhesion molecule) and Negr1 (neuronal growth regulator1)37–39.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
What the sources say
- Not checked — no full text of the sourcecites [37] Pimenta, A.F. et al. The limbic system-associated membrane protein is an Ig superfamily member that mediates selective neuronal growth and axon targeting. Neuron 15, 287–297 (1995). source
- Not checked — no full text of the sourcecites [38] Schofield, P.R. et al. Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact. EMBO J. 8, 489–495 (1989). source
- Partly supportedcites [39] Struyk, A.F. et al. Cloning of neurotrimin defines a new subfamily of differentially expressed neural cell adhesion molecules. J. Neurosci. 15, 2141–2156 (1995). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable in our copy) identifies LAMP, neurotrimin and OBCAM as members of a subfamily of Ig-like cell adhesion molecules, supporting the Lsamp, Ntm and Opcml portion of the claim. It does not identify Negr1 as a member or use the name IgLON. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Mutations in the gene are associated with a type of Stickler syndrome, a connective tissue disorder characterized by ocular, skeletal, orofacial and auditory defects35.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
What the sources say
- Supportedcites [35] Snead, M.P. & Yates, J.R. Clinical and molecular genetics of Stickler syndrome. J. Med. Genet. 36, 353–359 (1999). source
The Molecular genetics section reports COL11A1 mutations in families with the type 2 vitreous phenotype of Stickler syndrome. The Abstract describes Stickler syndrome’s ophthalmological and orofacial features, deafness, and joint disease, supporting the listed ocular, orofacial, auditory, and skeletal defects. Page numbers are not indicated for these passages. (LLM, conf=0.93)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As positive controls, we used Necl1-Fc and Necl4-Fc42,43, which, as expected, bound to oligodendrocytes and axons, respectively.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
What the sources say
- Supportedcites [42] Spiegel, I. et al. A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination. Nat. Neurosci. 10, 861–869 (2007). source
The Discussion reports that Necl1–Fc bound to oligodendrocytes in mixed cortical cultures. The Results report that Necl4–Fc robustly labeled axons of cultured DRG neurons. Page numbers were not supplied in our copy. (LLM, conf=0.92)
- Partly supportedcites [43] Maurel, P. et al. Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination. J. Cell Biol. 178, 861–874 (2007). sourceExperimental — accuracy not yet measured
The Results section, “Necl proteins mediate adhesion to neurons and Schwann cells” (page not provided), reports Necl-4-Fc binding to DRG neurites, supporting the axon portion. It reports Necl-1-Fc binding to Schwann cells, not oligodendrocytes; the oligodendrocyte portion is not established by this paper. (LLM, conf=0.87)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Ncam1 (Fig. 6b),a protein that negatively regulates myelination36.”
- Also stated in: § Discussion · plain
“Ncam1, a protein that negatively regulates myelination36.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
What the sources say
- Partly supportedcites [36] Charles, P. et al. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc. Natl. Acad. Sci. USA 97, 7585–7590 (2000). sourceExperimental — accuracy not yet measured
The Discussion reports that PSA-NCAM acts as a negative signal for myelination, and the Results show increased myelination after masking or removing its PSA moieties. The citing sentence attributes this effect to Ncam1 generally, but the paper establishes it specifically for polysialylated NCAM, not NCAM regardless of its polysialylation state. (LLM, conf=0.87)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Also stated in: § Discussion · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The identified 17,634 transcripts from the RNA sequencing showed a bimodal distribution, where one-third of the transcripts were of low abundance, possibly as a result of stochastic transcription28.”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
What the sources say
- Partly supportedcites [28] Hebenstreit, D. et al. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 7, 497 (2011). sourceExperimental — accuracy not yet measured
The Results and discussion describe two expression classes and an emerging low-expression peak after correcting for RNA-seq detection limits. They say the microarray distribution is clearly bimodal, however, while the uncorrected RNA-seq distribution has a low-expression shoulder. The passages do not substantiate 17,634 identified transcripts, a one-third low-abundance fraction, or stochastic transcription as the explanation for that fraction. (LLM, conf=0.87)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“We observed differences in the proteome and transcriptome with Pearson correlation coefficients between 0.40 and 0.45, somewhat poorer than those previously reported for cell lines15, but in the range of recent comparisons of human tissues16.”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
What the sources say
- Supportedcites [15] Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011). source
The Results and discussion report a proteome–transcriptome correlation of 0.6 in the HeLa cell line, supporting the cited comparison with a higher previously reported cell-line correlation. The 0.40–0.45 Pearson coefficients are the citing authors’ own observation, not a result attributed to this source; the source reports a Spearman correlation, so the metrics differ. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [16] Wilhelm, M. et al. Mass-spectrometry-based draft of the human proteome. Nature 509, 582–587 (2014). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that oligodendrocytes expressed the smallest number (341 proteins) of cell type-specific proteins, defined by the greater than tenfold fold enrichment criterion, and cortical neurons the largest (669 proteins).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Definition of global differences between CNS cell proteomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Between different cell types, correlations were much lower, from 0.48 to 0.84 for the proteome (Fig. 2a) and from 0.25 to 0.86 for the transcriptome (Supplementary Fig. 3).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Assessment of proteome quality and comparison to the transcriptome
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This corresponds to an average of 11,970 different proteins in each of these systems, of which 10,529 proteins were identified in all five cell types and brain (Fig. 1b,c).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > CNS cell-type proteome depth and quantification
plainn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar to the comparison between the different cell types, GO-based enrichment analysis revealed that cell surface proteins were highly overrepresented in the group of the most abundant brain-versus liver-enriched proteins and four out of the top five GOCC terms were related to membranes (Supplementary Table 16).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > The most abundant and enriched proteins inthe brain proteome
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The cell type-specific proteins in microglia had functions in membrane trafficking (Rab32, Myo1f), lipid catabolism (Apobr, Lipa) and signaling at the cell surface (CD180, Dock2, Nckap1l,Gpnmb, Fermt3), whereas proteins with designated functions in actin-related processes (Cnn1, Fmn2, Nebl, Pdlim7, Synpo2) and cilia (Rsph1, Ccdc39) were enriched in astrocytes.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Definition of global differences between CNS cell proteomes
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In fact, in all four cell types, ∼ 30–40 of the most abundant proteins accounted for ∼25% of the total protein molecules, and some of these were cell type specific (for oligodendrocytes Mbp, Plp, Cnp1; for cortical neurons Atp1b1, Crmp1, Gpm6a; for astrocytes Gfap, Gstm1, Prdx6; and for microglia Gm5483; Fig. 3b).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Definition of global differences between CNS cell proteomes
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The large majority of proteins were expressed in all four cell types, whereas only about 15% of the quantified proteins could be considered to be cell type specific (>10-fold more abundant in one cell compared with all others; Supplementary Table 6).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Definition of global differences between CNS cell proteomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The top 50 cell type-specific proteins (the most enriched and abundant proteins) included many well-established cell type-specific markers, but, based on PubMed search, also a relatively large number of proteins that have previously not been studied in the context of the respective cell type (more than one-third of the 50 proteins in the various glial types).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Definition of global differences between CNS cell proteomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The 12,934 proteins identified in different CNS cell types correspond to 11,690 ENSEMBL genes, which represents ∽60% of all protein coding genes in the genome.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > CNS cell-type proteome depth and quantification
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Consistent with their hematopoietic origin, microglia were the most diverging cell type; and, as expected from their shared lineage, astrocytes and oligodendrocytes were closest to each other (Fig. 2b).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Assessment of proteome quality and comparison to the transcriptome
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As judged by principal component analysis (PCA) and hierarchical clustering, the optic nerve, the cerebellum and the brain stem were the most diverging brain regions, whereas the remaining seven regions clustered more tightly (Fig. 5a,b).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Analysis of protein expression in brain regions
plaincorrelationaln = 10- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Whereas Necl1-Fc, used as a positive control, promoted growth and spreading of oligodendrocytes, cells did not attach and grow on Lsamp-Fc coated coverslips (Fig. 8f,g).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using antibody staining, we confirmed the expression of Lsamp in oligodendrocytes and neurons, but not in astrocytes or microglia (Fig. 7e,f).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In total, we identified 2,901 brain region-enriched proteins (>4-fold difference) and found that the thalamus expressed the smallest and the optic nerve the largest numbers of brain region-enriched proteins (154 and 1,179, respectively; Supplementary Tables 17 and 18).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Analysis of protein expression in brain regions
plainn = 10- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunofluorescence staining of cultured cells showed that Col11A1 can be used as a new marker for immature oligodendrocytes and immunohistochemistry of brain sections revealed a weak association of Col11A1 with white matter tracts (Supplementary Fig. 8).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These analyses identified proteins of the extracellular matrix (Col11A1, Col1A1, Col1A2, Col4A1, Col3A1, Col5A2), of which Col11A1 was the most highly expressed and enriched protein.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, most family members were enriched in neurons and oligodendrocytes (except of Ntm, which was only enriched in neurons; Fig. 6c).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Prph, Sncg and Serpinb1b were most abundant and enriched in the brain stem, Omp and S100a5 in the olfactory bulb, Ppp1r1b, Actn2 and Pde10a in the striatum, and Plcb4, Prkcd and Synpo2 in the thalamus (Fig. 5c).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Analysis of protein expression in brain regions
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Microglia cells constitute the third class of glial cells with functions mainly related to immune response and maintaining brain homeostasis25.”
§ Cell type– and brain region–resolved mouse brain proteome > Abstract
What the sources say
- Not checked — no full text of the sourcecites [25] Hanisch, U.K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394 (2007). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Glia are not only abundant (constituting 50–90% of the cells in the human brain), but are also highly specialized toward cell type-selective tasks, and therefore ideally suited for these analyses21.”
§ Cell type– and brain region–resolved mouse brain proteome > Abstract
What the sources say
- Not checked — no full text of the sourcecites [21] Barres, B.A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60, 430–440 (2008). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Oligodendrocytes are primarily engaged in membrane synthesis, as their function is to insulate axons by enwrapping them with a multilamellar myelin sheath22,23.”
§ Cell type– and brain region–resolved mouse brain proteome > Abstract
What the sources say
- Not checked — no full text of the sourcecites [22] Sherman, D.L. & Brophy, P.J. Mechanisms of axon ensheathment and myelin growth. Nat. Rev. Neurosci. 6, 683–690 (2005). source
- Not checked — no full text of the sourcecites [23] Aggarwal, S., Yurlova, L. & Simons, M. Central nervous system myelin: structure, synthesis and assembly. Trends Cell Biol. 21, 585–593 (2011). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Between biological replicates of the same cell types, Pearson’s correlation coefficients were about 0.96, demonstrating excellent technical and biological reproducibility (Fig. 2a).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Assessment of proteome quality and comparison to the transcriptome
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The expression levels of cell type-specific markers for astrocytes (Aqp4, Gfap, Aldh1l1), oligodendrocytes (Cnp1, Mbp, Plp1), microglia (Iba1, Tlr2, Tlr7) and neuronal progenitors (Bcl11a, Bcl11b, Ebf3) showed that almost all of these markers were reproducibly enriched at least 16-fold, also confirming the quality of the proteome analysis (Supplementary Fig. 6a).”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Proteome analysis of acutely isolated CNS cell types
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The expression levels of well-described markers for astrocytes (Aquaporin 4, Gfap, Glast and Aldh1l1), oligodendrocytes (Cnp1, Sox10, Mbp, Mag, Mog, Plp1), cortical neurons (neurofilament, Snap25, synaptotagmin I, Gabra 2), cerebellar granule neurons (Synaptotagmin I, Snap25, Sv2b, Gprin1, L1cam) and microglia (Iba1, Tlr2, Tlr7, CD86) in our triplicate proteome analysis revealed that almost all of”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Assessment of proteome quality and comparison to the transcriptome
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Together these analyses of our deep primary cell proteomes faithfully reproduce known and characteristic cellular functions as well as their markers, providing a solid foundation for their global characterization and for new discoveries.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Assessment of proteome quality and comparison to the transcriptome
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“All four IgLONs are glycosylphosphati-dylinositol (GPI)-anchored glycoproteins with three Ig domains that have been implicated in cell adhesion and growth guidance in neurons, but not in glia.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We filtered for 8,147 protein groups that were quantified in all replicates for at least one cell type or its differentiation stage.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Downstream bioinformatics analyses
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All statistical analyses were performed on at least three different biological replicates.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Statistical analyses
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“our data and the rapidity with which it can now be generated, suggest that MS-based proteomics can be implemented more broadly into neuroscience to help resolve the full molecular complexity of the brain at the protein level, with cellular or even subcellular resolution.”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“it tests and computes the difference of every protein annotation from the overall intensity distribution using the two-sided Wilcoxon-Mann-Whitney test where the multiple hypothesis testing is adjusted by applying a Benjamini-Hochberg FDR threshold of 0.02.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Downstream bioinformatics analyses
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Differentially expressed proteins were identified by an ANOVA based test at permutation-based FDR cutoff of 0.05.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Downstream bioinformatics analyses
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Protein identification required at least one unique or razor peptide per protein group.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > MS data analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We performed two-sample welch t-tests to identify proteins with a significant differential expression in a cell type in comparison to others employing a 2% permutation-based FDR filter.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Downstream bioinformatics analyses
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“only cultures of at least 95% purity were included in further experiments.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Immunocytochemistry
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Blinded quantification was performed by determining areas of the myelinated and unmyelinated axons.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Electron microscopy
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The sample size was similar or higher to those generally employed in the field.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Statistical analyses
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“PLL coating (100 μg ml-1) was used as a positive control to verify the quality of the primary oligodendrocyte preparation.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Adhesion assay
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The replicates were grouped based on cell type and differentiation stage before applying an ANOVA test on the annotation matrix with a permutation-based FDR cutoff of 0.001 to identify annotation terms that are significantly different between at least two groups.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Downstream bioinformatics analyses
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We believe that these technological advances can be used broadly in the proteomic study of diverse and rare brain cell types.”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Apart from identifying a previously unknown negative regulator of myelination in specific fiber tracts of the CNS, these results exemplify the utility of our proteome resource.”
§ Cell type– and brain region–resolved mouse brain proteome > Results > Identification of Lsamp as a negative regulator of myelination
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Commonly used filtering criteria forRNA-Seq reduced the number to 12,933, indicating that our proteome coverage is close to completion, at least in terms of detection of each functionally expressed gene.”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“the required FDR was set to 1% at the peptide and protein level.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > MS data analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Lsamp is known to mediate homophilic, as well as heterophilic, interactions with other members of the IgLON family48.”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
What the sources say
- Not checked — no full text of the sourcecites [48] Gil, O.D. et al. Complementary expression and heterophilic interactions between IgLON family members neurotrimin and LAMP. J. Neurobiol. 51, 190–204 (2002). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All animal experiments were performed according to the Lower Saxony State regulations for animal experimentation.”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Tissue preparation, cell culture and cell isolation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
How proteomes differ among specialized cells in tissue is not known.
“Proteins are the main functional components in all cells, but how the proteomes differ in specialized cells in tissue is not known.”
The paper relies on this without support.
The molecular nature of axon-glia interaction is unknown.
“Given that the molecularnature of axon and glia interaction is unknown”
The authors state this as an assumption.
Data distribution was assumed to be normal but not formally tested.
“Data distribution was assumed to be normal but this was not formally tested.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Protein expression data of isolated mouse brain cells was generated by Sharma and colleagues [14] using Magnetic-Activated Cell Sorting (MACS) to isolate microglia, astrocytes, oligodendrocytes, and neurons from the brains of young (P8) C57/BL6 mice (3 biological replicates), analysed by mass spectrometry.”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We examined our previously generated proteome database for oligodendrocyte specific proteins and noticed that BCAS1 was one of the most enriched proteins in oligodendrocytes (21).”
From BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions (2017) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The transcriptome, however, is often not an accurate indicator of protein abundance (Liu et al., 2016), especially in complex brain tissue (Sharma et al., 2015).”
From Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression (2020) · cites this paper as Sharma et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“we exploited publicly available proteomics data derived from isolated mouse brain cells [14] and found that, at the protein level, oligodendrocytes indeed contain high levels of APP, BACE1, and PSEN1 (S1 Fig).”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [14]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Hephaestin is known to be expressed in the brain [45].”
From Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons (2016) · cites this paper as [45]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, proteomics analysis of cell preparations from mouse brain showed that MVP and ANXA2 were upregulated, whereas hnRNPH1, AGO1 and AGO4 were downregulated in astrocytes compared to neurons [70].”
From Differential RNA packaging into small extracellular vesicles by neurons and astrocytes (2021) · cites this paper as [70]
Experimental — accuracy not yet measuredIn the citing paper
“mRNA-protein correlation coefficients reach no higher than 0.47 even in acutely isolated brain cell types (Sharma et al., 2015).”
From A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease (2017) · cites this paper as Sharma et al., 2015
In the citing paper
“Unique splicing of Bin1 in microglia and oligodendroglia not seen in neurons or astrocytes has also been suggested [59, 67] and Bin1 has also been identified as a highly abundant microglial protein in a recent microglial proteome [68] although the exact role of Bin1 in homeostatic microglia and in AD pathogenesis remains unclear.”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [68]
In the citing paper
“a similar number of proteins has been shown to be expressed in native neurons”
From A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes (2018) · cites this paper as Sharma et al., 2015
In the citing paper
“Conversely, junctions that were observed in neurons, but not in microglia, had higher peptide coverage (fold change of neuronal to microglial mean: 2.3) in neuronal mass-spectral data sets 43 (Fig. 3d).”
From Single-cell isoform RNA sequencing characterizes isoforms in thousands of cerebellar cells (2018) · cites this paper as [43]
In the citing paper
“Neuronal and microglial peptides have recently been identified in young mouse brains 43 .”
From Single-cell isoform RNA sequencing characterizes isoforms in thousands of cerebellar cells (2018) · cites this paper as [43]
In the citing paper
“The MACS approach has been successfully applied to enrich four brain cell types (neuronal progenitors, microglia, astrocytes, and oligodendrocytes) from adult mice for high-resolution MS-based proteomics [97].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [97]
In the citing paper
“The cell type “character” of each module can be assessed by examining the overlap of module protein membership with cell type specific protein expression data [5, 17].”
From Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease (2018) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cell type– and brain region–resolved mouse brain proteome > Results > CNS cell-type proteome depth and quantification
“RNA sequencing (RNA-Seq) using the Illumina platform resulted in 19,501 unique gene symbols that were expressed in at least one cell type (Fig. 1e and Supplementary Table 3).”
§ Cell type– and brain region–resolved mouse brain proteome > Discussion
“The identified 17,634 transcripts from the RNA sequencing showed a bimodal distribution, where one-third of the transcripts were of low abundance, possibly as a result of stochastic transcription28.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cell type– and brain region–resolved mouse brain proteome > Results > CNS cell-type proteome depth and quantification
“Lysates were prepared from neurons and oligodendrocytes at different stages of development (1, 2.5 and 4 d in vitro for oligodendrocytes, and 5, 10 and 15 d in vitro for cortical neurons).”
§ Cell type– and brain region–resolved mouse brain proteome > Online Methods > Tissue preparation, cell culture and cell isolation
“The third day, AraC was washed out and cells were cultivated in neuronal growth medium until day 5, 10 and 16, respectively.”
Citations
Cites
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Self-citationKim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Universal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
Self-citationGenome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572 · cited 1×
“Q4 8,478 3 (299) 6 (35) 4 (6) 3 (1) 392 123 39 Q3 Q2 Q1 Astrocytes Microglia”
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr101065j · Cited by 5,520
Self-citationCox, J., Hein, M. Y., Luber, C. A., Paron, I., Nagaraj, N., & Mann, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031591 · Cited by 5,180
Self-citationIn-gel digestion for mass spectrometric characterization of proteins and proteomes
Shevchenko, A., Tomas, H., Havli, J., Olsen, J. V., & Mann, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.468 · Cited by 4,947
Self-citationZhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · cited 1×
“Q4 8,478 3 (299) 6 (35) 4 (6) 3 (1) 392 123 39 Q3 Q2 Q1 Astrocytes Microglia”
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Self-citationSoftware for Computing and Annotating Genomic Ranges
Lawrence, M. F., Huber, W. K., Pagès, H., Aboyoun, P., Carlson, M. R. J., Gentleman, R. C., Morgan, M. T., & Carey, V. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003118 · Cited by 4,475
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Vogel, C., & Marcotte, E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3185 · Cited by 4,195
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Self-citationCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“Q4 8,409 7 (614) 7 (42) 6 (10) 9 (3) 400 144 34 Q3 Q2 Q1 Percent (n) cell specific Oligodendrocytes Cortical neurons”
A draft map of the human proteome
Kim, M.-S., Pinto, S. M., Getnet, D., Nirujogi, R. S., Manda, S. S., Chaerkady, R., Madugundu, A. K., Kelkar, D. S., Isserlin, R., Jain, S., et al. (2014) · Nature · doi:10.1038/nature13302 · Cited by 2,198
Spatio-temporal transcriptome of the human brain
Kang, H. J., Kawasawa, Y. I., Cheng, F., Zhu, Y., Xu, X., Li, M., Sousa, A. M. M., Pletikos, M., Meyer, K. A., Sedmak, G., et al. (2011) · Nature · doi:10.1038/nature10523 · Cited by 2,084
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Correlation of mRNA and protein in complex biological samples
Maier, T., Güell, M., & Serrano, L. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.036 · Cited by 1,802
The microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511 · cited 1×
“Q4 7,940 1 (112) 2 (9) 2 (3) 10 (3) 370 124 29 Q3 Q2 Q1 Neurons total”
The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352
White matter in learning, cognition, and psychiatric disorders
Fields, R. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.04.001 · Cited by 1,337
Global signatures of protein and mRNA expression levels
de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., & Vogel, C. (2009) · Molecular BioSystems · doi:10.1039/b908315d · Cited by 1,248
A translational profiling approach for the molecular characterization of CNS cell types
Heiman, M., Schaefer, A., Gong, S., Peterson, J. D., Day, M., Ramsey, K. E., Suárez-Fariñas, M., Schwarz, C., Stephan, D. A., Surmeier, D. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.028 · Cited by 1,134
Deep proteome and transcriptome mapping of a human cancer cell line
Nagaraj, N., Wisniewski, J. R., Geiger, T., Cox, J., Kircher, M., Kelso, J., Pääbo, S., & Mann, M. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.81 · Cited by 979
Self-citationApplication of a translational profiling approach for the comparative analysis of CNS cell types
Doyle, J. P., Dougherty, J. D., Heiman, M., Schmidt, E. F., Stevens, T. R., Ma, G., Bupp, S., Shrestha, P., Shah, R. D., Doughty, M. L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.029 · Cited by 912
The quantitative proteome of a human cell line
Beck, M., Schmidt, A., Malmstroem, J., Claassen, M., Ori, A., Szymborska, A., Herzog, F., Rinner, O., Ellenberg, J., & Aebersold, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.82 · Cited by 816
Geiger, T., Wehner, A., Schaab, C., Cox, J., & Mann, M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014050 · Cited by 797
Self-citationAstrocytes and disease: a neurodevelopmental perspective
Molofsky, A. V., Krenick, R., Ullian, E., Tsai, H.-H., Deneen, B., Richardson, W. D., Barres, B. A., & Rowitch, D. H. (2012) · Genes & Development · doi:10.1101/gad.188326.112 · Cited by 682
Mechanisms of axon ensheathment and myelin growth
Sherman, D. L., & Brophy, P. J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1743 · Cited by 668
Johnson, M. B., Kawasawa, Y. I., Mason, C. E., Krsnik, Ž., Coppola, G., Bogdanović, D., Geschwind, D. H., Mane, S. M., State, M. W., & Šestan, N. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.027 · Cited by 603 · cited 1×
“Q4 7,898 2 (174) 4 (21) 6 (8) 11 (3) 368 117 28 Q3 Q2 Q1 Microglia total”
Marguerat, S., Schmidt, A., Codlin, S., Chen, W., Aebersold, R., & Bähler, J. (2012) · Cell · doi:10.1016/j.cell.2012.09.019 · Cited by 571
Characterization of the proteome, diseases and evolution of the human postsynaptic density
Bayés, À., van de Lagemaat, L. N., Collins, M. O., Croning, M. D. R., Whittle, I. R., Choudhary, J. S., & Grant, S. G. N. (2011) · Nature Neuroscience · doi:10.1038/nn.2719 · Cited by 499
Myelin Membrane Wrapping of CNS Axons by PI(3,4,5)P3-Dependent Polarized Growth at the Inner Tongue
Snaidero, N., Möbius, W., Czopka, T., Hekking, L. H. P., Mathisen, C., Verkleij, D., Goebbels, S., Edgar, J. M., Merkler, D., Lyons, D. A., et al. (2014) · Cell · doi:10.1016/j.cell.2013.11.044 · Cited by 477
Self-citationClinical and molecular genetics of Stickler syndrome
Snead, M. P., & Yates, J. R. W. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.5.353 · Cited by 448 · cited 1×
“Q4 8,478 3 (299) 6 (35) 4 (6) 3 (1) 392 123 39 Q3 Q2 Q1 Astrocytes Microglia”
Nagaraj, N., Alexander Kulak, N., Cox, J., Neuhauser, N., Mayr, K., Hoerning, O., Vorm, O., & Mann, M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013722 · Cited by 392
Self-citationDefining the transcriptome and proteome in three functionally different human cell lines
Lundberg, E., Fagerberg, L., Klevebring, D., Matic, I., Geiger, T., Cox, J., Älgenäs, C., Lundeberg, J., Mann, M., & Uhlen, M. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.106 · Cited by 373
Self-citationThe Coming Age of Complete, Accurate, and Ubiquitous Proteomes
Mann, M., Kulak, N. A., Nagaraj, N., & Cox, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.029 · Cited by 350
Self-citationA High-Resolution Spatiotemporal Atlas of Gene Expression of the Developing Mouse Brain
Thompson, C. L., Ng, L., Menon, V., Martı́nez, S., Lee, C., Glattfelder, K. J., Sunkin, S. M., Henry, A. M., Lau, C., Dang, C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.033 · Cited by 332
Charles, P., Hernandez, M. P., Stankoff, B., Aigrot, M. S., Colin, C., Rougon, G., Zalc, B., & Lubetzki, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100076197 · Cited by 306
Global Proteome Analysis of the NCI-60 Cell Line Panel
Gholami, A. M., Hahne, H., Wu, Z., Auer, F. J., Meng, C., Wilhelm, M., & Kuster, B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.018 · Cited by 302
Central nervous system myelin: structure, synthesis and assembly
Aggarwal, S., Yurlova, L., & Simons, M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.06.004 · Cited by 301
Self-citationRNA sequencing reveals two major classes of gene expression levels in metazoan cells
Hebenstreit, D., Fang, M., Gu, M., Charoensawan, V., van Oudenaarden, A., & Teichmann, S. A. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.28 · Cited by 289
Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma
Wiśniewski, J. R., Ostasiewicz, P., Duś, K., Zielińska, D. F., Gnad, F., & Mann, M. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.44 · Cited by 248
Self-citationA central role for Necl4 (SynCAM4) in Schwann cell–axon interaction and myelination
Spiegel, I., Adamsky, K., Eshed, Y., Milo, R., Sabanay, H., Sarig-Nadir, O., Horresh, I., Scherer, S. S., Rasband, M. N., & Peles, E. (2007) · Nature Neuroscience · doi:10.1038/nn1915 · Cited by 226 · cited 1×
“Q4 8,409 7 (614) 7 (42) 6 (10) 9 (3) 400 144 34 Q3 Q2 Q1 Percent (n) cell specific Oligodendrocytes Cortical neurons”
A global view of protein expression in human cells, tissues, and organs
Pontén, F., Gry, M., Fagerberg, L., Lundberg, E., Asplund, A., Berglund, L., Oksvold, P., Björling, E., Hober, S., Kampf, C., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.93 · Cited by 222
Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites
Trajkovic, K., Dhaunchak, A. S., Goncalves, J. T., Wenzel, D., Schneider, A., Bunt, G., Nave, K.-A., & Simons, M. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200509022 · Cited by 186
Self-citationMaurel, P., Einheber, S., Galinska, J., Thaker, P., Lam, I., Rubin, M. B., Scherer, S. S., Murakami, Y., Gutmann, D. H., & Salzer, J. L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705132 · Cited by 177
Cell-Type-Resolved Quantitative Proteomics of Murine Liver
Azimifar, S. B., Nagaraj, N., Cox, J., & Mann, M. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.002 · Cited by 173
Self-citationPimenta, A. F., Zhukareva, V., Barbe, M. F., Reinoso, B. S., Grimley, C., Henzel, W., Fischer, I., & Levitt, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90034-9 · Cited by 172
Struyk, A., Canoll, P., Wolfgang, M., Rosen, C., D'Eustachio, P., & Salzer, J. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02141.1995 · Cited by 142
Myelin basic protein‐dependent plasma membrane reorganization in the formation of myelin
Fitzner, D., Schneider, A., Kippert, A., Möbius, W., Willig, K. I., Hell, S. W., Bunt, G., Gaus, K., & Simons, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601376 · Cited by 135
Self-citationSchofield, P. R., McFarland, K. C., Hayflick, J. S., Wilcox, J. N., Cho, T. M., Roy, S., Lee, N. M., Loh, H. H., & Seeburg, P. H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03402.x · Cited by 126
Gil, O. D., Zanazzi, G., Struyk, A. F., & Salzer, J. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-22-09312.1998 · Cited by 111
Beck, M., Claassen, M., & Aebersold, R. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.09.002 · Cited by 83
Schnell, C., Shahmoradi, A., Wichert, S. P., Mayerl, S. E., Hagos, Y., Heuer, H., Rossner, M. J., & Hülsmann, S. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0645-0 · Cited by 79
Self-citationRegen, T., van Rossum, D., Scheffel, J., Kastriti, M. E., Revelo, N. H., Prinz, M., Brück, W., & Hanisch, U. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.10.009 · Cited by 70
Self-citationDecoding neuroproteomics: integrating the genome, translatome and functional anatomy
Kitchen, R. R., Rozowsky, J. S., Gerstein, M. B., & Nairn, A. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3829 · Cited by 63
Gil, O. D., Zhang, L., Chen, S., Ren, Y. Q., Pimenta, A., Zanazzi, G., Hillman, D., Levitt, P., & Salzer, J. L. (2002) · Journal of Neurobiology · doi:10.1002/neu.10050 · Cited by 61
Reed, J. E., Dunn, J. R., Du Plessis, D. G., Shaw, E. J., Reeves, P., Gee, A. L., Warnke, P. C., Sellar, G. C., Moss, D. J., & Walker, C. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00786.x · Cited by 61
Reed, J., McNamee, C., Rackstraw, S., Jenkins, J., & Moss, D. (2004) · Journal of Cell Science · doi:10.1242/jcs.01261 · Cited by 52
Limbic system associated membrane protein as a potential target for neuropsychiatric disorders
Innos, J., Koido, K., Philips, M., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00032 · Cited by 29
Self-citation
Cited by
Sorted by citations
On the Dependency of Cellular Protein Levels on mRNA Abundance
Liu, Y., Beyer, A., & Aebersold, R. (2016) · Cell · doi:10.1016/j.cell.2016.03.014 · Cited by 3,221
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334
Self-citationRevisiting biomarker discovery by plasma proteomics
Geyer, P. E., Holdt, L. M., Teupser, D., & Mann, M. (2017) · Molecular Systems Biology · doi:10.15252/msb.20156297 · Cited by 917
“…the power of cutting edge MS-based proteomics, cell lines can now routinely be quantified to a depth of more than 10,000 different proteins in a relatively short time, sometimes even without any fractionation (Mann et al, 2013; Richards et al, 2015; Sharma et al, 2015; Bekker-Jensen et al, 2017).”
BackgroundSelf-citationSingle-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation
Jordão, M. J. C., Sankowski, R., Brendecke, S. M., Sagar, Locatelli, G., Tai, Y.-H., Tay, T. L., Schramm, E., Armbruster, S., Hagemeyer, N., et al. (2019) · Science · doi:10.1126/science.aat7554 · Cited by 843
“Only recently, comprehensive profiling of bulk populations of CNS macrophages, including of entire transcriptomes (10) and proteomes (11), has helped to uncover several myeloid cell states during homeostasis (12) and disease (13).”
BackgroundSingle-cell transcriptomic profiling of the aging mouse brain
Ximerakis, M., Lipnick, S. L., Innes, B. T., Simmons, S. K., Adiconis, X., Dionne, D., Mayweather, B. A., Nguyen, L., Niziolek, Z., Ozek, C., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0491-3 · Cited by 736
Metadata
- Authors
- Sharma, K., Schmitt, S., Bergner, C. G., Tyanova, S., Kannaiyan, N., Manrique-Hoyos, N., Kongi, K., Cantuti, L., Hanisch, U.-K., Philips, M.-A., Rossner, M. J., Mann, M., & Simons, M.
- Affiliations
- Max Planck Institute of Biochemistry (DE)
- Max Planck Institute of Experimental Medicine (DE)
- Ludwig-Maximilians-Universität München (DE)
- University of Tartu (EE)
- University of Göttingen (DE)
- Corresponding author
- Mann, Matthias
- Simons, Mikael
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2015-11-02
- Volume
- 18
- Issue
- 12
- Pages
- 1819-1831
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC7116867
- OpenAlex
- W1955394435
- Cited by
- 785
- References
- 61
- Citations by year
- 2026: 50 · 2025: 55 · 2024: 69 · 2023: 80 · 2022: 85 · 2021: 76 · 2020: 89 · 2019: 81 · 2018: 84 · 2017: 67 · 2016: 45 · 2015: 1
- FWCI
- 25.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- GRO (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- oligodendrocytes, astrocytes, microglia, cortical neurons, cell surface proteins, adhesion molecules, LSAMP, myelination, neuron-glia interactions
- MeSH terms
- Animals, Brain, Humans, Male, Mice, Inbred C57BL, Neurons, Mice, Knockout, Proteome, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review